MeiraGTx's innovative gene therapies for ocular diseases & more are backed by strong clinical data and funding. Click here to find out why MGTX stock is a Buy.
With a storied history in vaccine development, India's Bharat Biotech is shaking things up and answering the call of advanced ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
HTX Research, the research arm of HTX Group, has released an in-depth report titled, "dTAO and the Evolution of Bittensor: Reshaping Decentralized AI with Market-Driven Incentives.". The evolution of ...
15h
Rest of World on MSNCareem’s CEO wants to transform the ride-hailing giant into a “digital butler” for everyday lifeMudassir Sheikha, who co-founded the Middle East-based ride-hailing giant, on Careem’s new chapter, its recipe for winning ...
Zevor-cel was approved by China's National Medical Products Administration (NMPA). <li /> As of December 31, 2024, ...
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced its 2024 ...
Brookhaven National Laboratory have discovered a new phase of matter while studying a model system of a magnetic material.
An international research team has conceived a dual-component controller for three-phase inverters that can reportedly ...
The company said its new Hienergy Series G2 product has a PV input ranging from 10 kW to 30 kW and storage capacity spanning ...
Cognizant (Nasdaq: CTSH) will today host an Investor Day, beginning at 1:00 p.m. ET. At the event, members of Cognizant's executive leadership team will outline the Company's progress against its ...
When the plasma inside a fusion system starts to misbehave, it needs to be quickly cooled to prevent damage to the device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results